Event Participants
Executives
2
Jaideep Barve, Shiva B. Kabra
Analysts
4
Saloni Arya, Saket Kapoor, Samarth Singh, Vineet Thakur
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Operating Revenue (Standalone) | ₹105 crores | +5% YoY vs ₹100 crores in Q1 FY26; growth tempered by polymer price volatility deferring consumables demand in extrusion, pipes and cables |
| Total Revenue (Standalone) | ₹107 crores | Includes other operating income; ~4-year prior annual revenues ranged ₹291-446 crores |
| Operating Revenue (Consolidated) | ₹115.56 crores | +3.8% YoY vs ₹111.28 crores in Q1 FY26; includes overseas subsidiaries (CP Italy, Markprint, Codeology) |
| Coding & Marking revenue share | ~95% | Most significant segment; new solutions in printers, inks and cartridges being added; price increase implemented |
| Printer units sold | 574 units | Q1 FY27 volume; Q1 seasonally slower with most sales closing in Q4/March |
| Export revenue share | 4-5% | Of Q1 revenue |
| COGS ratio (Standalone) | 42% of operating revenue | Improved from 44% in Q1 FY26; procurement optimization and cost control |
| COGS ratio (Consolidated) | 43% of operating revenue | vs 42% in Q1 FY26; subsidiary mix impact |
| Manufacturing costs | 3% of operating revenue | In line with prior periods |
| Depreciation | ~4% of operating revenue | Consistent with earlier periods |
| Track & Trace revenue (FY26) | ~₹20 crores | Full-year FY26; division at breakeven or mildly profitable |
| Investment in V-Shapes (CP Italy) | ~₹65 crores | Cumulative investment to date; tech-transfer IP purchase expected to be the last material infusion |
Geographic & Segment Commentary
Coding & Marking (India): Largest segment at ~95% of operating revenue. Q1 demand softness in pipes, extrusion and cables driven by polymer price volatility linked to the Iran conflict; management expects normalisation. Market leader in cement, plywood, sugar and dairy verticals; top verticals include Pipes, Food, Dairy, Cable & Wire, FMCG, Steel & Metal and Wood. COGS improved to 42% (from 44% YoY); one price increase plus a surcharge implemented to recover sticky input cost inflation.
Packaging – CP Italy/V-Shapes: In stabilisation mode; co-packaging traction improving with a growing pipeline, laminates business in early stages. Machine reliability remains the key constraint; management is cutting back-office/operations manpower, adding sales resources, and localising material manufacturing in-house. Breakeven guidance pushed to H1 FY28. Approximately 70+ V-Shape machines in the market (pre-acquisition) are mostly not running due to system complexity.
Track & Trace: FY26 revenue ~₹20 crores, roughly breakeven; plain-vanilla business steady. Innovative QRiousCodes solutions in pilots with 2-3 large pharma companies, with outcomes expected in Q2 FY27. Current TAM ~₹600 crores annually; potential expansion to ~₹1,500 crores if the government mandate extends from top 300 brands to top 1,000 brands.
Subsidiaries – Markprint & Codeology: Markprint's digital printing technology localised into Control Print's own solutions and actively sold; Codeology's print-and-apply offering localised and available for sale, targeting a segment where competitors generate ~₹25-30 crores each annually. International businesses expected to breakeven in FY27; sales executed from India increasingly bypass subsidiary P&Ls.
Company-Specific & Strategic Commentary
- V-Shapes execution overhaul: Management deliberately slowed machine sales to fix reliability and changeover complexity before scaling; internal co-packaging in India and Italy is stable, final machine changes are being tested. Demand is confirmed across food (price-sensitive), pharma (long gestation), cosmetics and nutraceuticals (best fit).
- Localisation of acquired technologies: Digital printing (Markprint) and print-and-apply (Codeology) solutions localised and commercialised in India; patents filed around new solutions.
- Pricing actions: One price increase plus a surcharge implemented since the Iran war began to recover margin erosion from sticky input cost inflation; management acknowledges a historically non-aggressive pricing stance.
- In-house material manufacturing: V-Shapes films and consumables being manufactured in-house for consistency and sharply improved material margins; Assam (UNNATI) expansion in limbo due to government suspension of the incentive scheme.
- Packaging distributor model: Under consideration for machine, co-packaging and laminate sales in India and overseas; management team strengthened with tighter operational controls.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Coding & Marking revenue growth | 10-15% for FY27 | Steady pipeline visibility; Q1 polymer-driven weakness expected to normalise; Q4 seasonality noted |
| Coding & Marking margins | ~60% gross margin, ~30% EBIT margin | Reference levels for core business excluding investments in other segments; price increases and surcharge to recover lost margin |
| Packaging (CP Italy/V-Shapes) breakeven | H1 FY28 | Delayed from H2 FY27; conditional on machine reliability fixes and cost streamlining; no further major cash infusion beyond IP tech transfer |
| International subsidiaries | Breakeven in FY27 | Markprint, Codeology, CP Italy; sales manpower increased while back-office reduced; India-based coordination strengthened |
| Track & Trace pilots | Visibility in Q2 FY27 | Three pharma customers in qualification (IQ/DQ/PQ); outcomes will determine scale-up decisions; further disclosures possible at Q3 |
| Track & Trace TAM expansion | ₹600 crores → ₹1,500 crores potential | Dependent on government mandate expanding from top 300 to top 1,000 brands (~2,000 to ~25,000 SKUs); still a discussion paper, implementation over 2 years if enacted |
Risks & Constraints
| Risk | Context |
|---|---|
| V-Shapes execution and market reputation | Machine changeover complexity and reliability issues have damaged the product's market reputation (70+ machines sold pre-acquisition mostly idle; peak 2021 sales EUR 12.5 million). Management is fixing execution before scaling sales; risk that reputation damage limits pipeline conversion despite confirmed demand. |
| Raw material price volatility | Iran conflict and polymer price swings (₹70-150 range) deferred extrusion/pipes customer purchases and compressed committed co-packaging margins in Q1. Volatility — not just price levels — is the primary constraint on customer behaviour. |
| Regulatory uncertainty | QR code mandate expansion (top 300 to top 1,000 brands) remains a discussion paper and may be diluted by industry lobbying; UNNATI incentive scheme for the Assam facility suspended until further notice, leaving committed equipment in limbo. |
| Foreign exchange fluctuations | Q1 standalone PBT compression was largely attributable to FX movements; management cites this as the main variance versus prior year. |
| Competitive intensity | Print-and-apply market already served by competitors generating ₹25-30 crores each annually; CPL is a late entrant. Packaging machine market reputation requires careful rebuilding to win repeat business. |
Q&A Highlights
V-Shapes: Demand vs. Execution Gap
- Question: Is V-Shapes' problem demand or execution? Who are the potential customers, geographies and use cases? (Samarth Singh)
- Answer: Demand exists — food is the biggest but price-sensitive; pharma is the best market with long gestation; cosmetics and nutraceuticals are the two biggest target industries with clear functional use cases. The issue is execution: the system is "fiddly," requiring experienced operators for changeovers; pre-acquisition machines (70+ in market, 2021 peak >EUR 12.5 million) mostly are not running. Management is slowing sales to perfect the product before scaling; internal co-packaging runs are stable but machine consistency is not fully resolved. (Shiva B. Kabra)
Core Business Health, Margins and Q1 Slowdown
- Question: How has the core domestic business performed ex-one-offs, and what is driving the profitability dip? (Saket Kapoor; Vineet Thakur)
- Answer: A few crores of consumable sales were lost due to Iran-related polymer price fluctuation, hitting the extrusion business specifically; no fundamental market change. Coding & Marking should deliver 10-12-15% growth this year with 60% gross / 30% EBIT margins ex-investments. Ex-FX fluctuations, PBT is largely unchanged YoY; Q2-Q4 pipeline is positive and consumable demand is normalising. (Shiva B. Kabra; Jaideep Barve)
Subsidiary Health and Future Capital Infusion
- Question: What is the status of each subsidiary, and how much more will be invested to support operations? (Saket Kapoor; Saloni Arya)
- Answer: Markprint's digital printing is localised and actively sold; Codeology's print-and-apply is localised, targeting a market competitors serve at ₹25-30 crores each. CP Italy is streamlining costs — reducing back-office/manpower, adding salespeople, and shifting coordination to India. International businesses should breakeven this year. The tech-transfer IP purchase (last material infusion into CP Italy) is in progress; no further major cash burn is expected after ~₹65 crores invested to date. (Shiva B. Kabra)
Track & Trace: Pharma Pilots and Timeline
- Question: What is the update on negotiations with the two large pharma companies? When will sales materialise? (Saloni Arya)
- Answer: Three pharma customers are in pilots going through IQ/DQ/PQ qualification; outcomes could differ across customers. Plain-vanilla Track & Trace already generates ~₹20 crores (FY26) at breakeven. The innovative QRiousCodes proposition will get its first real market readout in Q2; disclosure may come at Q3 depending on outcomes. (Shiva B. Kabra)
Track & Trace: TAM and Government QR Code Mandate
- Question: What is the total addressable market, and what does the expanded government QR code regulation mean? (Raj Vyas; Parag Hinde via Q&A box)
- Answer: TAM is
₹500-600 crores annually (equipment plus software); CPL is at ~₹20 crores. The government's discussion paper proposes expanding from top 300 brands (2,000 SKUs) to top 1,000 brands plus antibiotics and psychotropics (~25,000 SKUs), potentially tripling the market to ~₹1,500 crores over a 2-year implementation. However, it is still a discussion paper facing industry lobbying; management cautions against assuming enforcement. (Jaideep Barve; Shiva B. Kabra)
V-Shapes Breakeven Timeline and Assam CapEx
- Question: Is V-Shapes breakeven still on track for H2 FY27? Is the Assam facility for co-packaging or other businesses? (Keval Shah)
- Answer: The packaging business will likely breakeven in H1 FY28, not H2 FY27; an update will be provided in Q2. The UNNATI Assam project (primarily co-packaging and film manufacturing, with some Coding & Marking planned) is in limbo — equipment is ordered but the government has suspended the incentive scheme until further notice. (Shiva B. Kabra)
QR Code Counterfeiting and Pricing Model
- Question: Has the QR code copying loophole been solved? What is the per-QR-code charge? (Chirag Barasara)
- Answer: No — counterfeiting of QR codes remains a serious problem; that is precisely what QRiousCodes aims to solve. Pricing is flexible: equipment sale plus per-QR-code fees, AMC, and/or line charges depending on customer preference; per-code pricing is bucketed by volume — high-value/low-volume products cost more, high-volume/low-value products cost less. (Shiva B. Kabra)
Exit Triggers for Underperforming Businesses
- Question: What is the internal reference point after which the company would pull the plug on underperforming businesses? (Ashutosh Singh)
- Answer: QRiousCodes is already breakeven; international businesses should reach breakeven this year. Development investment in digital printing solutions will continue. If the packaging business shows no path forward, management will not hesitate to take a tough call — but the current issue is poor execution, not absence of opportunity or demand. (Shiva B. Kabra)
Key Takeaway
Control Print's Q1 FY27 standalone operating revenue grew 5% YoY to ₹105 crores (₹100 crores in Q1 FY26), with consolidated operating revenue at ₹115.56 crores (+3.8% YoY), as polymer price volatility from the Iran conflict deferred consumables demand in extrusion, pipes and cables. The core Coding & Marking segment (95% of revenue) improved COGS to 42% of revenue (from 44%), and recent price increases plus a surcharge are expected to restore margins toward the 60% gross / 30% EBIT reference levels. Management guides 10-15% Coding & Marking growth for FY27, with 574 printers sold in Q1 and Track & Trace (₹20 crores FY26 revenue) at breakeven. Strategic focus remains the V-Shapes execution turnaround — breakeven pushed to H1 FY28 with no further material cash infusion beyond IP transfer — and QRiousCodes pharma pilots where a mandate expansion could lift TAM from ₹600 crores to ₹1,500 crores. Watch items: CP Italy machine reliability and reputation, raw material volatility, FX swings, and the suspended UNNATI subsidy scheme.